The day's signal
A small Osaka leather-goods maker withdrew from Rakuten Market after the e-commerce giant said it would help deliver defense drones to Japan's defense ministry. What looks like a niche retail dispute is actually a crack in Japan's postwar consensus.
Nvidia is now mass-producing its Groq3 LPX inference chips at Samsung Foundry, a move that breaks its reliance on TSMC and signals the hard launch of an inference-first AI arms race. Customers are already locked in, including Navius and SpaceXAI.
Korean firms sold dollars at nearly four times last year's pace in Q2, flooding the market with export proceeds and pushing the won to a 13-month low. The government's currency-stability push is now squeezing the very companies it aimed to protect.
The protracted Iran conflict is accelerating the UAE's transformation from weapons buyer into a defense-AI manufacturing and export hub. A new US-UAE task force, relaxed export controls, and a flood of foreign tech firms signal a shift that could redraw global arms-supply chains.
Nvidia's Groq 3 LPU benchmarks deliver staggering token speeds, but the real story lies in a strategic pivot that could reshape AI infrastructure economics. The company is betting that inference—not training—will fund the next decade of chip revenue, even as competitors like Cerebras and AMD prepare heterogeneous counterattacks.
Kyiv's all-drone parade on its 35th independence day was more than symbolism. It was a public declaration that the robotics model Ukraine has built through five years of war is now the template the world's militaries are racing to replicate.
Hanmi Pharmaceutical's ¥3.2 trillion exclusive deal with Genentech for HM17321 marks the largest K-biotech obesity-license exit to date. The drug's non-incretin UCN2 mechanism targets a problem Big Pharma hasn't solved: preserving muscle while patients lose weight on GLP-1s.
Seven straight days of selling for the world's most valuable chipmaker isn't normal even for Nvidia. What's behind the rout — and what it could mean for global AI infrastructure spending.
At a European summit marking 4½ years of war, Zelenskyy's refusal to surrender — paired with the UK's unprecedented disclosure of missile component details — signals Ukraine is preparing the West for a long fight. Putin's hardline stance leaves no diplomatic off-ramp.
Robert F. Kennedy Jr. is exploring a radical overhaul of how the US categorizes vaccine recommendations — a move that could erode public trust and send shockwaves through global immunization programs.
Hanmi Pharma's $1.9 billion upfront deal with Genentech for an obesity drug candidate signals a turning point for Korean biotech — no longer just making drugs for foreigners, but selling them their own science at scale.
Nine people, including Nvidia and Super Micro employees, face charges in Taiwan for smuggling banned AI servers to China. The case reveals how sophisticated and pervasive evasion networks have become — and why export enforcement remains a moving target.